ScanBalt Digital Forum 2020

4 September 2020, Germany.
ScanBalt invites European cluster organisations to join the formulation of a joint declaration on the necessary next steps to create the Common European Health Data Space. Clusters are invited to draw on the experience of their cluster members such as universities, hospitals, research institutions, pharmaceutical and med-tech companies and start-ups. The Joint Declaration will be presented to the German Council Presidency for its Council conclusions and further recommendations.

The current COVID 19 crises raises awareness of the need of data and best practise exchange and underlines the need for action. To learn and be better prepared for the future, it is important to gather the innovative digital solutions from the different areas of care, for example:

  • Research (exchange of patient-related data in cross-border research projects, for example in infectiology or pharmacology)
  • Patient care and nursing (cross-border coordination of capacities)
  • Use of innovative digital apps (e.g. early warning system for new waves of infection or for monitoring social distancing measures)
  • Suggestions for a fast track approval of digital solutions

Our aim is to collect and analyse the input on the above-mentioned topics and to formulate the joint declaration to be discussed at the ScanBalt Forum on the 4th of September 2020.

Due to potential travel restrictions, the ScanBalt Forum 2020 will be held for the first time as a purely digital conference. The Forum will focus on the examples that are provided by European cluster organizations and will bound these examples together with the help of panel discussions to a Joint Declaration. The Forum, as the Joint Declaration, has four Tracks:

  • The cross-country collaboration on healthcare between European member states. The COVID-19 crisis has shown that we urgently need new possibilities for health data exchange across borders.
  • Digital solution for the next generation of health research. University hospitals, research institutions, pharmaceutical /medtech companies and public health authorities rely on the possibility to exchange data for improving their business and the treatment of the European public.
  • Digital solutions for a resilient population protection. COVID-19 has underlined the need for a consolidated and harmonized European digital infrastructure (tracing/early pandemic warning systems etc.). The future of the European idea of open borders and freedom of movement relies also on those technical solutions.
  • Digital solutions for a protective elderly care and health care systems. In this chapter we will examine how digital solution could improve healthcare and elderly care systems regarding COVID-19 treatment and beyond.

For further information and to register, please visit:
https://scanbalt.org/scanbaltforum2020/

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...